News & Events
Press Releases
-
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
June 26, 2018 -
Aquinnah Pharmaceuticals Receives $3.4M Grant from NINDS To Advance New Therapies for ALS
June 20, 2018 -
LabCentral "Golden Ticket" Submission
June 12, 2018 -
Pfizer Opens a Call For Proposals For LabCentral Residency
June 11, 2018 -
Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency
June 06, 2018 -
Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing
May 21, 2018 -
ReviveMed turns drug discovery into a big data problem and raises $1.5 M to solve it
May 21, 2018 -
HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders
May 16, 2018 -
Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
May 03, 2018 -
Servier backs American startup’s research project at LabCentral
April 26, 2018